Dataset Information


Internet survey on the actual situation of constipation in the Japanese population under 70 years old: focus on functional constipation and constipation-predominant irritable bowel syndrome.

ABSTRACT: BACKGROUND:In Japan, the prevalence of constipation-predominant irritable bowel syndrome (IBS-C) and functional constipation (FC) diagnosed by the Rome III criteria is unclear, as are the demographic profile, quality of life (QOL), and habits of persons with IBS-C or FC. METHODS:We performed an internet survey of constipation. After extracting 3000 persons fitting the composition of the general Japanese population, we investigated demographic factors, lifestyle, defecation, and laxatives. IBS-C and FC were diagnosed by Rome III criteria. Respondents also completed the Japanese IBS severity index (IBS-SI-J), Japanese IBS QOL scale (IBS-QOL-J), SF-8, Hospital Anxiety and Depression Scale (HADS), and Japanese Health Practice Index (JHPI). RESULTS:There were 262 respondents with FC (8.73%) [73 men and 189 women; mean age: 49.8?±?13.1 years; mean body mass index (BMI): 21.0?±?3.3 g/m2] and 149 respondents with IBS-C (4.97%) (76 men and 73 women; mean age; 41.6?±?13.7 years; mean BMI: 20.8?±?3.0 kg/m2). Total IBS-QOL-J score were significantly lower in the IBS-C group than the FC group. With regard to SF-8, score of mental component summary (MCS) was significantly lower in the IBS-C group. The total IBS-SI-J score and item scores, except for satisfactory defecation, were significantly higher in the IBS-C group than the FC group. HADS showed a significant increase of anxiety and depression in both the groups, and the JHPI revealed insufficient sleep. CONCLUSIONS:In Japan, among the population of under 70 years old, the prevalence of IBS-C and FC (Rome III criteria) was 4.97% and 8.76%, respectively. IBS-C caused more severe symptoms than FC, resulting in impairment of QOL.

SUBMITTER: Kawamura Y 

PROVIDER: S-EPMC6942565 | BioStudies | 2020-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5056578 | BioStudies
2015-01-01 | S-EPMC4424385 | BioStudies
1000-01-01 | S-EPMC5628990 | BioStudies
2018-01-01 | S-EPMC6169046 | BioStudies
1000-01-01 | S-EPMC5355501 | BioStudies
2020-01-01 | S-EPMC7646105 | BioStudies
2020-01-01 | S-EPMC7269025 | BioStudies
2020-01-01 | S-EPMC7455223 | BioStudies
2016-01-01 | S-EPMC5172545 | BioStudies
2016-01-01 | S-EPMC4949702 | BioStudies